Literature DB >> 8339804

Dynamics of eosinophil infiltration in the bronchial mucosa before and after the late asthmatic reaction.

R Aalbers1, J G de Monchy, H F Kauffman, M Smith, Y Hoekstra, B Vrugt, W Timens.   

Abstract

We wanted to determine whether changes in bronchial hyperresponsiveness (BHR) following allergen challenge show a time relationship with inflammatory events in the airways of allergic asthmatic subjects. Lavage was performed and endobronchial biopsies were taken via the fiberoptic bronchoscope, before, and 3 and 24 h after, allergen challenge, on separate occasions, in nine dual asthmatic responders. The numbers of activated eosinophils, identified by immunohistochemistry, using the monoclonal anti-eosinophil cationic protein antibody, EG2, were significantly increased both at 3 h and at 24 h in the submucosa and bronchial lavage. A significant negative correlation was found between the number of EG2+ cells in the submucosa and in the bronchial lavage 24 h after the allergen challenge (r = -0.70). At 24 h, the amount of eosinophil cationic protein (ECP) was increased in the bronchial lavage. A significant correlation was observed between the amount of ECP at 3 h and the log provocative dose of house dust mite producing a 20% fall in forced expiratory volume in one second (PD20 HDM) (r = -0.63). The results suggest a recruitment of activated eosinophils to the submucosa and, further, to the epithelial lining, followed by degranulation. This process has already started 3 h after allergen challenge, and lasts for at least 24 h, which may result in mucosal damage and subsequent allergen-induced increase in BHR, before and after the late asthmatic reaction.

Entities:  

Mesh:

Year:  1993        PMID: 8339804

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Role of airway eosinophilia and eosinophil activation in Sephadex-induced inflammation.

Authors:  Karim Maghni; François Nantel; Chantal Lanoue; Solange Cloutier; Jean-Paul Cristol; Alain Cadieux; Pierre Sirois
Journal:  Inflammation       Date:  2004-08       Impact factor: 4.092

2.  Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation.

Authors:  J R Brown; J Kleimberg; M Marini; G Sun; A Bellini; S Mattoli
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

3.  Systemic eosinophil response induced by respiratory syncytial virus.

Authors:  C A Lindemans; J L L Kimpen; B Luijk; J Heidema; D Kanters; C K van der Ent; L Koenderman
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

4.  Effect of cyclosporin A on the allergen-induced late asthmatic reaction.

Authors:  B S Sihra; O M Kon; S R Durham; S Walker; N C Barnes; A B Kay
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

Review 5.  Resolution of leucocyte-mediated mucosal diseases. A novel in vivo paradigm for drug development.

Authors:  Carl Persson; Lena Uller
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 6.  Resolution of cell-mediated airways diseases.

Authors:  Carl G Persson; Lena Uller
Journal:  Respir Res       Date:  2010-06-11

Review 7.  Cellular and immunological markers of allergic and intrinsic bronchial asthma.

Authors:  J C Virchow; C Kroegel; C Walker; H Matthys
Journal:  Lung       Date:  1994       Impact factor: 2.584

8.  Inflammatory cell distribution in guinea pig airways and its relationship to airway reactivity.

Authors:  F Westerhof; W Timens; A van Oosten; A B Zuidhof; N Nauta; M Schuiling; J T Vos; J Zaagsma; H Meurs; W Coers
Journal:  Mediators Inflamm       Date:  2001-06       Impact factor: 4.711

9.  Mast Cell-Activated Bone Marrow Mesenchymal Stromal Cells Regulate Proliferation and Lineage Commitment of CD34(+) Progenitor Cells.

Authors:  Zoulfia Allakhverdi; Michael R Comeau; Myriam Armant; Rachana Agrawal; Judith A Woodfolk; Roma Sehmi; Karen J Howie; Gail M Gauvreau; Guy Delespesse
Journal:  Front Immunol       Date:  2013-12-17       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.